A Portfolio of Novel Research Tools
We pride ourselves on our collaboration with many different institutes and organisations worldwide. In particular, the institutes who are pushing the boundaries of research tool production. It is these very collaborations that allows us to offer you such a vast range of novel and diverse research tools. Here are some examples of the unique research tools you can access through our portfolio.
Plasmax is a cell culture medium designed to imitate the physiological profile of human plasma. This medium allows you to: grow your cell cultures in conditions that realistically mirror human physiological conditions, simplify your medium preparation process, and reduce inter- and intra- experimental variability. Read our case study below to uncover more about the future of cancer cell culture.
Finding new and improved approaches for identifying and tracking specific markers is important in research. Fluorescent probes can be directed at virtually any marker, with agents available to target specific organelles, proteins, lipids and macromolecules. Our portfolio contains fluorescent probes that target peroxisomes, the endoplasmic reticulum and lipids.
Recombinant antibodies are rapidly expanding in popularity. Providing benefits in flexibility and reproducibility, they are increasingly being used in a variety of cancer research areas. Check out our antibodies portfolio below.
Simplifying your search for a wide variety of cell lines to add to your portfolios can help save you time. Our portfolio includes cell lines from a vast global network of institutes, including the laboratories of Nobel Prize winner, Sir Peter Ratcliffe; Charles Janeway, the father of Innate Immunity; industry leader, Professor Irene Leigh; and leading institutes such as the University of Cambridge, Uppsala University, and A*STAR in Singapore.
Explore our research tool portfolio
CancerTools.org, the research tools arm of Cancer Research UK, is a non-profit, global community of cancer researchers, academic institutes and societies, with a shared mission to accelerate cancer research discoveries. In this collaborative, researchers contribute research tools and share knowledge to deepen our understanding of cancer, and drive innovation within cancer research.